Caspase-8 in inflammatory diseases: a potential therapeutic target
Wangzheqi Zhang,
No information about this author
Chenglong Zhu,
No information about this author
Yan Liao
No information about this author
et al.
Cellular & Molecular Biology Letters,
Journal Year:
2024,
Volume and Issue:
29(1)
Published: Oct. 8, 2024
Caspase-8,
a
renowned
cysteine-aspartic
protease
within
its
enzyme
family,
initially
garnered
attention
for
regulatory
role
in
extrinsic
apoptosis.
With
advancing
research,
growing
body
of
evidence
has
substantiated
involvement
other
cell
death
processes,
such
as
pyroptosis
and
necroptosis,
well
modulatory
effects
on
inflammasomes
proinflammatory
cytokines.
PANoptosis,
an
emerging
concept
death,
encompasses
pyroptosis,
apoptosis,
providing
insight
into
the
often
overlapping
cellular
mortality
observed
during
disease
progression.
The
activation
or
deficiency
caspase-8
enzymatic
activity
is
closely
linked
to
positioning
key
regulator
survival
across
various
physiological
pathological
processes.
Aberrant
expression
associated
with
development
progression
range
inflammatory
diseases,
including
immune
system
disorders,
neurodegenerative
diseases
(NDDs),
sepsis,
cancer.
This
paper
delves
impact
these
conditions,
aiming
elucidate
potential
therapeutic
strategies
future
intervention.
Language: Английский
Contemporary insights and prospects on ferroptosis in rheumatoid arthritis management
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Sept. 24, 2024
Rheumatoid
arthritis
(RA)
is
a
common
autoimmune
disease
characterized
primarily
by
persistent
synovial
inflammation
and
joint
destruction.
In
recent
years,
ferroptosis,
as
novel
form
of
cell
death,
has
garnered
widespread
attention
due
to
its
critical
role
in
various
diseases.
This
review
explores
the
potential
mechanisms
ferroptosis
RA
relationship
with
pathogenesis
RA,
systematically
analyzing
regulatory
cells,
chondrocytes,
immune
cells.
We
emphasize
evaluation
ferroptosis-related
pathways
their
therapeutic
targets,
including
development
application
inhibitors
activators.
Although
shows
some
promise
treatment,
dual
safety
issues
clinical
still
require
in-depth
study.
Future
research
should
focus
on
elucidating
specific
pathology
developing
more
effective
safer
strategies
provide
new
treatment
options
for
patients.
Language: Английский
Nanodrug delivery systems targeting ferroptosis as an innovative therapeutic approach for Rheumatoid Arthritis
Xiaolin Dai,
No information about this author
Yu‐Jun Zheng,
No information about this author
J. J. Cui
No information about this author
et al.
Materials Today Bio,
Journal Year:
2025,
Volume and Issue:
32, P. 101804 - 101804
Published: April 25, 2025
Rheumatoid
Arthritis
(RA)
is
a
chronic
inflammatory
disease
characterized
by
joint
inflammation,
progressive
cartilage
degradation,
and
bone
erosion.
Recent
research
has
implicated
ferroptosis
not
only
in
autoimmune
hepatitis
but
also
the
pathogenesis
progression
of
disorders
like
RA.
Consequently,
numerous
therapeutic
strategies
have
begun
to
target
pathway,
particularly
design
development
nanodrug
delivery
systems
(NDDSs).
While
previous
reviews
comprehensively
discussed
mechanisms
ferroptosis,
related
signaling
pathways,
NDDS
materials,
recent
studies
further
elucidated
interplay
between
various
metabolic
providing
robust
theoretical
basis
for
NDDS-based
strategies.
This
review
focuses
on
investigating
role
RA,
aiming
elucidate
how
targeting
can
offer
novel
concepts
potential
treatments
RA
patients.
Specifically,
it
summarizes
ferroptosis-based
NDDSs
via
different
pathways
highlights
feasibility
treatment
regimens
based
mechanism.
Furthermore,
critically
discusses
current
limitations
offers
perspectives
future
directions
this
field.
Language: Английский
Nanometer preparation of natural bioactive compounds for treatment of rheumatoid arthritis
Junping Zhu,
No information about this author
Xiang Qin,
No information about this author
Qi Li
No information about this author
et al.
Journal of Pharmaceutical Analysis,
Journal Year:
2025,
Volume and Issue:
unknown, P. 101341 - 101341
Published: May 1, 2025
Language: Английский
Ferroptosis in Arthritis: Driver of the Disease or Therapeutic Option?
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(15), P. 8212 - 8212
Published: July 27, 2024
Ferroptosis
is
a
form
of
iron-dependent
regulated
cell
death
caused
by
the
accumulation
lipid
peroxides.
In
this
review,
we
summarize
research
on
impact
ferroptosis
disease
models
and
isolated
cells
in
various
types
arthritis.
While
most
studies
have
focused
rheumatoid
arthritis
(RA)
osteoarthritis
(OA),
there
limited
spondylarthritis
crystal
arthropathies.
The
effects
inducing
or
inhibiting
strongly
depend
studied
type.
search
for
new
therapeutic
targets,
chondrocytes
might
promising
any
type
On
other
hand,
induction
may
also
lead
to
desired
decrease
synovial
fibroblasts
RA.
Thus,
must
consider
cell-type-specific
Further
investigation
needed
clarify
these
complexities.
Language: Английский
Decoding ferroptosis: transforming orthopedic disease management
Guochen Huo,
No information about this author
Yumeng Lin,
No information about this author
Lusheng Liu
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 6, 2024
As
a
mechanism
of
cell
death,
ferroptosis
has
gained
popularity
since
2012.
The
process
is
distinguished
by
iron
toxicity
and
phospholipid
accumulation,
in
contrast
to
autophagy,
apoptosis,
other
death
mechanisms.
It
implicated
the
advancement
multiple
diseases
across
body.
Researchers
currently
know
that
osteosarcoma,
osteoporosis,
orthopedic
disorders
are
caused
NRF2,
GPX4,
star
proteins.
effective
relief
osteoarthritis
symptoms
from
deterioration
been
confirmed
clinical
treatment
with
inhibitors.
At
same
time,
it
should
be
reminded
mechanisms
involved
regulate
not
understood.
In
this
manuscript,
we
present
discovery
ferroptosis,
role
variety
diseases.
We
expect
manuscript
can
provide
new
perspective
on
diagnosis
related
Language: Английский
Siweixizangmaoru Decoction Ameliorated Type II Collagen-Induced Arthritis in Rats <i>via</i> Regulating JAK2–STAT3 and NF-κB Signaling Pathway
Yanfei Niu,
No information about this author
Qianjing Feng,
No information about this author
Mingxue Cui
No information about this author
et al.
Biological and Pharmaceutical Bulletin,
Journal Year:
2024,
Volume and Issue:
47(9), P. 1511 - 1524
Published: Sept. 12, 2024
Siweixizangmaoru
decoction
(SXD)
is
widely
used
as
an
anti-rheumatoid
arthritis
(RA)
in
Tibet,
however,
the
specific
anti-inflammatory
mechanism
of
SXD
still
unclear.
This
research
attempts
to
examine
efficacy
and
possible
mechanisms
treating
RA.
The
primary
chemical
components
were
identified
using
UHPLC-Q-Exactive
Orbitrap
MS.
We
established
a
lipopolysaccharide
(LPS)-induced
RAW264.7
macrophage
inflammatory
injury
model
explore
validated
it
through
vivo
experiments.
According
our
vitro
well
vivo,
exhibits
qualities.
can
suppress
nitric
oxide
(NO)
pro-inflammatory
factor
production
cells
activated
by
LPS.
underlying
this
effect
might
be
connected
janus
tyrosine
kinase
2-signal
transducer
activator
transcription
3
(JAK2/STAT3)
nuclear
factor-κB
(NF-κB)
signaling
pathways.
In
alleviates
joint
swelling,
decreases
generation
factors
serum,
lowers
oxidative
stress,
improves
damage.
short,
degeneration
symptoms
associated
with
RA
regulating
inflammation
via
suppression
NF-κB
JAK2/STAT3
pathway
activation.
Language: Английский